Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Controlled low central venous pressure (CLCVP) technology
The First People's Hospital of Lianyungang
Acute Kidney Injury
1 trial -
Conventional second-line therapy
The First People's Hospital of Lianyungang
Colorectal Cancer (CRC)
1 trial -
Conventional third-line therapy
The First People's Hospital of Lianyungang
Colorectal Cancer (CRC)
1 trial -
Conventional treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Copd Exacerbation Acute
1 trial -
Cordyceps cicadae
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Visual Acuity
2 trials -
Coronary Computed Tomography Angiography
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cardiovascular Primary Prevention Strategy
1 trial -
Coronary Computed Tomography Angiography
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Statin
1 trial -
Coronary Computed Tomography Angiography
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Major Adverse Cardiovascular Events (MACE)
1 trial -
Corticosteroid
Beijing Anzhen Hospital
Heart Valve Diseases
1 trial -
Corticosteroid
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Heart Valve Diseases
1 trial -
Cow's milk
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Respiratory Infection
1 trial -
Crystalloid
Hospital Authority, Hong Kong
Acute Kidney Injury
1 trial -
Cy-TB test
International Peace Maternity and Child Health Hospital
Latent Tuberculosis
1 trial -
Cyclophosphamide
Ultragenyx UK Limited
Systemic Lupus Erythematosus
1 trial -
Cyclosporin A
The First People's Hospital of Lianyungang
Acute Leukemia
1 trial -
DC-TC+GM-CSF
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Primary Hepatocellular Carcinoma
1 trial -
DPP4
The First People's Hospital of Lianyungang
Type 2 Diabetes Mellitus
1 trial -
Da Jian Zhong Tang (Zanthoxylum, Ginger, Ginseng, Maltose)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
ERAS
1 trial -
Dapagliflozin
Hospital Authority, Hong Kong
Diabetes Mellitus, Type 2
1 trial -
Dapagliflozin Treatment Group
The First People's Hospital of Lianyungang
Atrial Fibrillation (AF)
1 trial -
Daphne Extract Capsules
The First People's Hospital of Lianyungang
Epithelial Ovarian Cancer
1 trial -
Daratumumab
The First People's Hospital of Lianyungang
Antibody-mediated Rejection
1 trial -
Dasatinib
The First People's Hospital of Lianyungang
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1 trial -
Dentoblis
The First People's Hospital of Lianyungang
Gingivitis; Chronic
2 trials
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources